Skip to main content

Discussion around the effects of a cannabinoid receptor 1 antagonist on THC-induced vascular inflammation

Please join us for a conversation about a study published in 2022 in the Journal Cell entitled: “Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation”, in which Dr. Chandy, and Dr. Sitbon discuss the potential therapeutic applications of genistein, a soybean isoflavone, on inflammation, oxidative stress and vascular dysfunction caused by Δ9-THC administration.

mm

Author Yoel H. Sitbon

Yoel is a Medical Writer in the Medical Content division at Csequence. His scientific expertise is in Neuroscience (neural mechanisms behind drug addiction) and Molecular & Cellular Pharmacology (molecular mechanisms behind mutations induced cardiovascular diseases). Yoel has over five years of scientific writing experience as evidenced by 8 peer-reviewed publications in scientific journals. He is an effective oral communicator having presented his PhD thesis work at many biomedical conferences nationally. He also has strong mentorship and leadership experience. Yoel has a B.S in Neuroscience at the University of California, Los Angeles and a Ph.D. in Molecular & Cellular Pharmacology at the University of Miami, Miller School of Medicine.

More posts by Yoel H. Sitbon